Randomized, Double-blind, Placebo/Active-controlled, Multi-center Clinical Trial to Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg After 14-day Oral Administration in Patients With Seasonal Allergic Rhinitis.
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2014
At a glance
- Drugs Bilastine (Primary) ; Desloratadine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Yuhan
- 09 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2013 Planned End Date changed from 1 Jun 2012 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 15 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.